Free Trial

Twist Bioscience (TWST) Competitors

Twist Bioscience logo
$38.03 -0.44 (-1.14%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$37.65 -0.38 (-1.00%)
As of 07/11/2025 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TWST vs. ADPT, BEAM, CRSP, TXG, VCYT, DNA, BPMC, BBIO, VRNA, and ROIV

Should you be buying Twist Bioscience stock or one of its competitors? The main competitors of Twist Bioscience include Adaptive Biotechnologies (ADPT), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), 10x Genomics (TXG), Veracyte (VCYT), Ginkgo Bioworks (DNA), Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), and Roivant Sciences (ROIV). These companies are all part of the "medical" sector.

Twist Bioscience vs. Its Competitors

Adaptive Biotechnologies (NASDAQ:ADPT) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Adaptive Biotechnologies has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500.

99.2% of Adaptive Biotechnologies shares are owned by institutional investors. 6.4% of Adaptive Biotechnologies shares are owned by company insiders. Comparatively, 3.0% of Twist Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Adaptive Biotechnologies had 4 more articles in the media than Twist Bioscience. MarketBeat recorded 13 mentions for Adaptive Biotechnologies and 9 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 0.60 beat Adaptive Biotechnologies' score of 0.51 indicating that Twist Bioscience is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adaptive Biotechnologies
4 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Twist Bioscience
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Adaptive Biotechnologies has higher earnings, but lower revenue than Twist Bioscience. Adaptive Biotechnologies is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adaptive Biotechnologies$189.53M9.47-$159.49M-$0.96-12.31
Twist Bioscience$347.68M6.55-$208.73M-$3.25-11.70

Adaptive Biotechnologies currently has a consensus target price of $10.57, suggesting a potential downside of 10.56%. Twist Bioscience has a consensus target price of $50.40, suggesting a potential upside of 32.53%. Given Twist Bioscience's higher possible upside, analysts clearly believe Twist Bioscience is more favorable than Adaptive Biotechnologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adaptive Biotechnologies
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Twist Bioscience
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70

Twist Bioscience has a net margin of -54.98% compared to Adaptive Biotechnologies' net margin of -74.84%. Twist Bioscience's return on equity of -33.48% beat Adaptive Biotechnologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Adaptive Biotechnologies-74.84% -62.79% -24.55%
Twist Bioscience -54.98%-33.48%-25.34%

Summary

Adaptive Biotechnologies and Twist Bioscience tied by winning 8 of the 16 factors compared between the two stocks.

Get Twist Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TWST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TWST vs. The Competition

MetricTwist BioscienceMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.28B$2.94B$5.56B$9.11B
Dividend YieldN/A2.42%5.06%4.01%
P/E Ratio-11.7020.8528.2620.26
Price / Sales6.55303.05437.10166.10
Price / CashN/A42.1137.1257.67
Price / Book4.717.638.045.49
Net Income-$208.73M-$55.05M$3.19B$250.45M
7 Day Performance-0.21%8.43%3.62%4.79%
1 Month Performance13.45%8.14%5.98%9.59%
1 Year Performance-28.84%1.62%29.39%16.41%

Twist Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TWST
Twist Bioscience
4.3885 of 5 stars
$38.03
-1.1%
$50.40
+32.5%
-28.8%$2.28B$347.68M-11.70990Gap Down
ADPT
Adaptive Biotechnologies
2.8825 of 5 stars
$11.74
-0.5%
$10.57
-10.0%
+195.5%$1.78B$178.96M-12.23790
BEAM
Beam Therapeutics
2.0931 of 5 stars
$19.18
-4.1%
$48.75
+154.2%
-21.3%$1.93B$63.52M-4.16510News Coverage
CRSP
CRISPR Therapeutics
3.2427 of 5 stars
$51.19
-1.9%
$71.75
+40.2%
-1.9%$4.42B$37.31M-11.33460News Coverage
Analyst Forecast
Options Volume
TXG
10x Genomics
4.5129 of 5 stars
$11.92
-8.4%
$14.96
+25.5%
-26.8%$1.47B$624.66M-9.171,240
VCYT
Veracyte
3.5949 of 5 stars
$26.34
-4.3%
$40.90
+55.3%
+19.0%$2.06B$445.76M64.25790
DNA
Ginkgo Bioworks
0.7876 of 5 stars
$11.38
-10.5%
$5.77
-49.3%
N/A$666.09M$237.42M-1.24640News Coverage
Gap Down
BPMC
Blueprint Medicines
1.2222 of 5 stars
$128.40
+0.0%
$128.06
-0.3%
+9.8%$8.29B$508.82M-51.98640Insider Trade
BBIO
BridgeBio Pharma
4.6657 of 5 stars
$43.50
-1.1%
$58.85
+35.3%
+71.3%$8.26B$221.90M-12.32400Analyst Upgrade
VRNA
Verona Pharma PLC American Depositary Share
2.3793 of 5 stars
$91.20
-0.4%
$107.36
+17.7%
+403.5%$7.76B$42.28M-45.6030Trending News
Analyst Forecast
ROIV
Roivant Sciences
3.0006 of 5 stars
$10.74
-2.3%
$17.50
+62.9%
+0.1%$7.30B$29.05M-42.96860News Coverage
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:TWST) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners